CRA-2059

Modify Date: 2024-01-10 22:31:07

CRA-2059 Structure
CRA-2059 structure
Common Name CRA-2059
CAS Number 256649-36-2 Molecular Weight 750.80
Density N/A Boiling Point N/A
Molecular Formula C34H46N12O8 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of CRA-2059


CRA-2059 is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase-β (rHTβ)[1][2].

 Names

Name CRA-2059

 CRA-2059 Biological Activity

Description CRA-2059 is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase-β (rHTβ)[1][2].
Related Catalog
In Vitro Tryptase is a trypsin-like serine protease found as a major protein component in human mast cell secretory granules. CRA-2059 has the potential for inflammatory bowel disease research[1].
References

[1]. Tremaine WJ, et al. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study. Aliment Pharmacol Ther. 2002;16(3):407-413.

[2]. Selwood T, et al. Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor. Biol Chem. 2003;384(12):1605-1611.

 Chemical & Physical Properties

Molecular Formula C34H46N12O8
Molecular Weight 750.80
Top Suppliers:I want be here

Get all suppliers and price by the below link:

CRA-2059 suppliers

CRA-2059 price

Related Compounds: More...
1-[7-[2,6-dibromo-4-(trifluoromethyl)phenyl]-2,5,6-trimethylpyrrolo[2,3-d]pyrimidin-4-yl]-3,6-dihydro-2H-pyridine-4-carboxamide
291538-79-9
CRA-026440 hydrochloride
847459-98-7
N-ethyl-4-[4-(3-fluorophenyl)-3,6-dihydro-2H-pyridin-1-yl]-6-methyl-N-(2-methylsulfanyl-4-propan-2-ylphenyl)pyrimidin-2-amine
226948-11-4
CRA-026440
847460-34-8
(2R)-2-[[2-[(6-carbamoyl-1H-benzimidazol-2-yl)methyl]-3-methylbenzimidazole-5-carbonyl]amino]-3-phosphonopropanoic acid
263870-19-5
[6-[[6-[4-[4-(5-acetyloxy-4-hydroxy-4,6-dimethyloxan-2-yl)oxy-5-hydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-7-(3,4-dihydroxy-1-methoxy-2-oxopentyl)-4,10-dihydroxy-3-methyl-5-oxo-7,8-dihydro-6H-anthracen-2-yl]oxy]-3-hydroxy-2-methyloxan-4
120381-88-6
benzenesulfonic acid,1-[8-(2,4-dichlorophenyl)-2-methylquinolin-4-yl]-3,6-dihydro-2H-pyridine-4-carboxamide
694491-71-9
Ibrutinib (PCI-32765)
936563-96-1
2-(2-hydroxyphenyl)-1H-indole-5-carboximidamide
179748-10-8
1-(trifluoromethyl)pyrrolidine-2,5-dione
2917586-13-9
1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-(3-methoxybenzyl)-3-piperidinecarboxamide
901731-33-7
2,6-Bis(methylene)bicyclo[2.2.2]octane
106139-95-1
1-[[4-(1H-Imidazol-1-ylmethyl)-3-methoxyphenyl]methyl]-2-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-1H-benzimidazol-5-ol
215656-87-4
N-[3-Fluoro-4-(4-morpholinyl)phenyl]benzenemethanamine
872991-73-6
N-[(1-methylpiperidin-4-yl)methyl]-3-(trifluoromethyl)benzamide
954016-73-0
4-(4-methoxyphenyl)-6-pentyl-3,4,6,7-tetrahydro-1H-pyrrolo[3,4-d]pyrimidine-2,5-dione
940786-27-6
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
N-(1,3-benzodioxol-5-ylmethyl)-2-(4-oxo-2-phenylpyrazolo[1,5-a]pyrazin-5(4H)-yl)acetamide
941920-56-5
5-Tert-butyloxycarbonyl-3-phenyl-4,6-dihydropyrrolo[3,4-c]pyrazole
657428-56-3